Sign In
Buy NDAQ
$77.65
-3.96 (-4.85%)
At Close: Jun 25, 2026
Nasdaq 100 and Crypto Stocks: Bitcoin's Rally Boosts Market Sentiment
09:38am, Thursday, 05'th Dec 2024
US stocks hold steady as Bitcoin soars past $100K, lifting crypto equities. Retail and tech stocks lead premarket moves.
Sol Strategies Applies For Listing on Nasdaq Exchange
07:54am, Thursday, 05'th Dec 2024
Toronto, Ontario--(Newsfile Corp. - December 5, 2024) - Sol Strategies Inc. (CSE: HODL) (OTC Pink: CYFRF) ("Sol Strategies" or the "Company"), a publicly traded Canadian company actively investing in,
Santech Holdings Limited Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement
06:14am, Thursday, 05'th Dec 2024
HONG KONG, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Santech Holdings Limited (NASDAQ: STEC) (“Santech” or the “Company”) announced today that it has received an extension of the period to regain comp
Nasdaq, Dow, S&P 500 hit records as tech surges, Fed Chair says economy in 'remarkably good shape'
05:17pm, Wednesday, 04'th Dec 2024
To get the latest market news check out finance.yahoo.com A tech rally boosted US stocks on Wednesday, with all three major indexes hitting new record closes, as investors digested Federal Reserve Cha
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
05:15pm, Wednesday, 04'th Dec 2024
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology announced the grant of an inducement award to a November new hire, as required under Nasdaq Listing Rule 5635(c)(4).
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:15pm, Wednesday, 04'th Dec 2024
RESEARCH TRIANGLE PARK, N.C., Dec. 04, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted f
Coinbase to Participate in 51st Nasdaq London Investor Conference
04:05pm, Wednesday, 04'th Dec 2024
Remote-First-Company/MIAMI--(BUSINESS WIRE)--Coinbase Global, Inc. announced today that Alesia Haas, Chief Financial Officer, will participate in a fireside chat at the 51st Nasdaq London Investor Con
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Wednesday, 04'th Dec 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare di
Nasdaq, S&P 500 hover near record highs as tech leads gains
02:58pm, Wednesday, 04'th Dec 2024
To get the latest market news check out finance.yahoo.com The S&P 500 (^GSPC) and tech-heavy Nasdaq Composite (^IXIC) touched intraday record highs on Wednesday as markets edged higher, buoyed by tech
New York, New York, Dec. 04, 2024 (GLOBE NEWSWIRE) -- FutureTech II Acquisition Corp. (the “Company”) (NASDAQ: FTII), today announced that it received an expected deficiency notification letter fr
5 Stocks Driving Nasdaq ETF to New Highs in 2024
11:00am, Wednesday, 04'th Dec 2024
Nasdaq achieves its 34th record closing high of the year. Here are the five best stocks of QQQ this year.
Nasdaq and S&P 500 hit record highs on Salesforce, Marvell gains
10:55am, Wednesday, 04'th Dec 2024
US equity benchmarks rose on Wednesday led by gains in technology shares such as Salesforce and Marvell Technology. At the time of writing, the Dow Jones Industrial Average was up 0.6%, while the S&
Cognizant to Present at the Nasdaq Investor Conference
08:00am, Wednesday, 04'th Dec 2024
TEANECK, N.J. , Dec. 4, 2024 /PRNewswire/ -- Cognizant (Nasdaq: CTSH), a leading provider of information technology, consulting, and business process services, today announced a presentation at th
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06:30am, Wednesday, 04'th Dec 2024
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVista's board of directors granted five new
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Tuesday, 03'rd Dec 2024
WALTHAM, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies fo
